|
NACC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.625200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.103400E-01 |
| Normal-vs-Stage2 |
5.534400E-01 |
| Normal-vs-Stage3 |
4.681100E-03 |
| Normal-vs-Stage4 |
8.482600E-01 |
| Stage1-vs-Stage2 |
4.010800E-01 |
| Stage1-vs-Stage3 |
2.536500E-03 |
| Stage1-vs-Stage4 |
7.328000E-01 |
| Stage2-vs-Stage3 |
5.739900E-02 |
| Stage2-vs-Stage4 |
8.570600E-01 |
| Stage3-vs-Stage4 |
1.148010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.921000E-01 |
| Normal-vs-AfricanAmerican |
5.888800E-01 |
| Normal-vs-Asian |
2.215600E-01 |
| Caucasian-vs-AfricanAmerican |
8.612800E-01 |
| Caucasian-vs-Asian |
2.480000E-01 |
| AfricanAmerican-vs-Asian |
7.457900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.162000E-01 |
| Normal-vs-Female |
2.484700E-03 |
| Male-vs-Female |
6.401500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.736600E-01 |
| Normal-vs-Extreme_Weight |
5.054800E-01 |
| Normal-vs-Obese |
8.390300E-02 |
| Normal-vs-Extreme_Obese |
5.553400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.474800E-01 |
| Normal_Weight-vs-Obese |
3.139800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.513800E-01 |
| Extreme_Weight-vs-Obese |
2.558000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.815200E-01 |
| Obese-vs-Extreme_Obese |
7.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.341700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.973000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.868000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.262800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.455100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.279400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.779900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.190400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.028300E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.756320E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.902200E-01 |
| Normal-VS-Type2 PRCC |
7.316600E-01 |
| Normal-VS-KIRP CIMP |
5.304200E-03 |
| Normal-VS-Unclassified PRCC |
1.706640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.889200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.862200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.952000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.399600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.755400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.244200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.865800E-01 |
| Normal-vs-N1 |
6.860200E-03 |
| Normal-vs-N2 |
1.389380E-01 |
| N0-vs-N1 |
1.517970E-02 |
| N0-vs-N2 |
3.006100E-02 |
| N1-vs-N2 |
9.615200E-01 |
|
|
